Presented in a sleek pharmaceutical-grade vial with premium green branding, this product is tailored for professional distributors, aesthetic suppliers, wellness businesses, and wholesale buyers seeking high-end peptide solutions with strong market positioning
Formula: dose in mg concentration in mg/mL = mL
It offers brand-name GLP-1s, along with personalized guidance, check-ins, and side-effect support, which may include additional medication
Some individuals achieve meaningful results at moderate dose levels without needing to increase further
But with list prices of roughly $1,000 a month, public and private payers are struggling to keep up with ballooning demand for GLP-1 weight loss drugs and in some cases are eliminating or restricting their coverage as a result
In 2025, Ozempic was approved by the US Food and Drug Administration (FDA) to reduce the risk of worsening kidney disease and kidney failure in people with type 2 diabetes